Magnesium Versus High Dose Fentanyl in Endotracheal Intubation
NCT ID: NCT04544163
Last Updated: 2021-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2020-09-05
2021-05-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Magnesium Sulphate Versus Fentanyl for Conscious Sedation in CSDH
NCT03548493
Does Adding Magnesium Sulphate to Low Dose Rocuronium Affects Depth of Blockade
NCT04510337
Magnesium Sulphate Versus Fentanyl Sedation During Burr-hole Surgery
NCT03854812
Efficacy Of Magnesium In Radicular Pain When Added To Local Anesthetics And Steroids In Transforaminal Epidural Injection
NCT04532775
Comparison Between Pregabalin and Magnesium Sulfate in Hypotensive Anaesthesia
NCT05442931
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Magnesium sulphate- Fentanyl
30 mg per kg MgSo4 infusion in 100 ml saline over 10 minutes
Magnesium sulfate- Fentanyl
drug administration before intubation
Fentanyl 2Mcg/kg
drug administration with induction of anesthesia
Fentanyl 4 mic
4 mic per kg fentanyl i.v
Fentanyl 4Mcg/kg
drug administration with induction of anesthesia
Fentanyl
2 mic per kg fentanyl i.v
Fentanyl 2Mcg/kg
drug administration with induction of anesthesia
Lidocaine- Fentanyl
Lidocaine 1.5 mg/kg
Fentanyl 2Mcg/kg
drug administration with induction of anesthesia
Lidocaine 1.5 mg/kg
drug administaration 90 sec before intubation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnesium sulfate- Fentanyl
drug administration before intubation
Fentanyl 4Mcg/kg
drug administration with induction of anesthesia
Fentanyl 2Mcg/kg
drug administration with induction of anesthesia
Lidocaine 1.5 mg/kg
drug administaration 90 sec before intubation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA I II
* 18 to 60
Exclusion Criteria
* renal or hepatic impairment
* hypertensive patients, patients with cardiovascular or cerebrovascular diseases
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Walaa Youssef Elsabeeny
Lecturer of anesthesia and pain management
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Walaa Y Elsabeeny, MD
Role: PRINCIPAL_INVESTIGATOR
Lecturer
Nahla N Shehab, MD
Role: PRINCIPAL_INVESTIGATOR
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Walaa Y Elsabeeny
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AP2007-50108
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.